Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VERV Verve Therapeutics > Detailed Quotes

VERV Verve Therapeutics

Watchlist
23.290
-0.720-3.00%
Close  02/03 16:00 ET
23.2900.0000.00%
Post Mkt Price 02/03 16:01 ET
High
24.290
Open
23.230
Turnover
13.22M
Low
22.920
Pre Close
24.010
Volume
561.35K
Market Cap
1.43B
P/E(TTM)
Loss
52wk High
43.000
Shares
61.60M
P/E(Static)
Loss
52wk Low
10.700
Float Cap
985.01M
Bid/Ask %
0.00%
Historical High
78.000
Shs Float
42.29M
Volume Ratio
0.87
Historical Low
10.700
Dividend TTM
--
Div Yield TTM
--
P/B
2.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.33%
Amplitude
5.71%
Avg Price
23.551
Lot Size
1
Float Cap
985.01M
Bid/Ask %
0.00%
Historical High
78.000
Shs Float
42.29M
Volume Ratio
0.87
Historical Low
10.700
Dividend TTM
--
P/B
2.62
Dividend LFY
--
Turnover Ratio
1.33%
Amplitude
5.71%
Avg Price
23.551
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines. Its goal is to disrupt the chronic care model for CVD by providing a new therapeutic approach with single-course in vivo gene editing treatments focused on addressing the root causes of this highly prevalent and life-threatening disease. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan and Burt A. Adelman in 2018 and is headquartered in Boston, MA.
CEO: Dr. Sekar Kathiresan, M.D.
Market: NASDAQ
Listing Date: 06/17/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist